AlmudenaGómez-‐Hernández&al.
342
40.
Boucher J, Castan-‐Laurell I, Le Lay S, Grujic D, Sibrac D, Krief S et al. Human alpha 2A-‐
adrenergic receptor gene expressed in transgenicmouse adipose tissue under the control
of its regulatoryelements. JMol Endocrinol. 2002; 29(2):251-‐64.
41.
Frühbeck G, Gómez-‐Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for
integration of endocrine and metabolic signaling in energy metabolism regulation. Am J
Physiol EndocrinolMetab. 2001; 280(6):E827-‐47.
42.
Martí A, Berraondo B, Martínez JA. Leptin: physiological actions. J Physiol Biochem. 1999;
55(1):43-‐9.
43.
MuellerWM, GregoireFM, StanhopeKL,Mobbs CV,MizunoTM,WardenCHet al. Evidence
that glucose metabolism regulates leptin secretion from cultured rat adipocytes.
Endocrinology. 1998; 139(2):551-‐8.
44.
Wellhoener P, Fruehwald-‐Schultes B, Kern W, Dantz D, Kerner W, Born J et al. Glucose
metabolismrather than insulin is amaindeterminant of leptin secretion inhumans. J Clin
EndocrinolMetab. 2000; 85(3):1267-‐71.
45.
NakataM, YadaT, SoejimaN,Maruyama I. Leptinpromotes aggregationof humanplatelets
via the long formof its receptor. Diabetes. 1999; 48(2):426-‐429.
46.
Mcgill, JB, Schneider, DJ, Arfken, CL, Lucore, CL. Factors responsable for impaired
fibrinolysis inobese subject andNIDDMpatiens. Diabetes1994; 43(1): 104-‐109.
47.
Palomer X, Pérez A, Blanco-‐Vaca F. Adiponectin: a new link between obesity, insulin
resistanceandcardiovasculardisease.MedClin(Barc)2005; 124(10):388-‐95.
48.
AritaY, KiharaS, OuchiN, TakahashiM,MaedaK,Miyagawa J et al. Paradoxical decreaseof
an adipose-‐specific protein, adiponectin, in obesity. BiochemBiophys Res Commun. 1999;
257(1):79-‐83.
49.
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma
concentrationsof anovel, adipose-‐specificprotein, adiponectin, in type2diabeticpatients.
ArteriosclerThrombVascBiol. 2000; 20(6):1595-‐9.
50.
PischonT, GirmanCJ, Hotamisligil GS, Rifai N, Hu FB, RimmEB. Plasma adiponectin levels
andriskofmyocardial infarction inmen. JAMA. 2004; 291(14):1730-‐7.
51.
Kazumi T, Kawaguchi A, Sakai K, HiranoT, YoshinoG. Youngmenwithhigh-‐normal blood
pressure have lower serumadiponectin, smaller LDL size, and higher elevated heart rate
than thosewithoptimal bloodpressure. DiabetesCare. 2002; 25(6):971-‐6.
52.
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J et al. Disruption of
adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;
277(29):25863-‐6.
53.
Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y et al. Adipocyte-‐derived
plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger
receptor expression in human monocyte-‐derived macrophages. Circulation. 2001;
103(8):1057-‐63.
54.
RyoM, Nakamura T, Kihara S, KumadaM, Shibazaki S, TakahashiMet al. Adiponectin as a
biomarkerof themetabolic syndrome. Circ J. 2004; 68(11):975-‐81.
55.
Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N et al. Osaka CAD
Study Group. Coronary artery disease. Association of hypoadiponectinemiawith coronary
arterydisease inmen. ArteriosclerThrombVascBiol. 2003; 23(1):85-‐9.
56.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS,
Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001 Jan
18;409(6818):307-‐12.
57.
Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C et al. Resistin is
expressed in human macrophages and directly regulated by PPAR gamma activators.
BiochemBiophysResCommun2003; 300(2):472-‐6.
58.
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue
expression of tumor necrosis factor-‐alpha in human obesity and insulin resistance. J Clin
Invest 1995; 95(5):2409–2415.
59.
Hotamisligil GS. Inflammationandmetabolicdisorders. Nature. 2006; 444(7121):860–867
60.
Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, et al. Accelerated
endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive
oxygenspecies. AmJ Physiol EndocrinolMetab. 2007; 293(5):E1311–E1319.
61.
Hotamisligil GS, Budavari A,MurrayD, SpiegelmanBM. Reduced tyrosinekinaseactivityof
the insulin receptor in obesitydiabetes. Central role of tumor necrosis factor. J Clin Invest
1994; 94(4):1543–1549
